This Week Health
Alex's Lemonade Stand This Week Health
May 22, 2024

Thoma Bravo-Owned LogRhythm Announces Merger With Rival Exabeam

publication
|
Summary
LogRhythm, owned by private equity firm Thoma Bravo, has announced a merger with its SIEM market competitor Exabeam. Financial details were not disclosed, but Exabeam's latest valuation was $2.5 billion. The merger aims to leverage complementary strengths in AI-driven threat detection, investigation, and response, offering enhanced R&D, product innovation, and expanded support. Exabeam provides a SIEM platform known for its behavioral analytics and automated threat response capabilities. The deal is anticipated to close in Q3 2024, pending regulatory approvals.

Explore Related Content

Get Daily Headlines Straight to Your Inbox.

Subscribe Now
This Week Health
Healthcare Transformation Powered by Community

Questions about the Podcast?

Contact us with any questions, requests, or comments about the show. We love hearing your feedback.

Hello@ThisWeekHealth.com

Looking to connect or attend events? Visit our sister organization, 229 Project
Click here.

© Copyright 2024 Health Lyrics All rights reserved